Lion Biotechnologies (Germany) Performance
| 2LB Stock | 8.80 0.63 7.71% |
The company secures a Beta (Market Risk) of 1.93, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lion Biotechnologies will likely underperform. At this point, Lion Biotechnologies has a negative expected return of -0.13%. Please make sure to verify Lion Biotechnologies' total risk alpha, kurtosis, market facilitation index, as well as the relationship between the value at risk and rate of daily change , to decide if Lion Biotechnologies performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors. ...more
Lion |
Lion Biotechnologies Relative Risk vs. Return Landscape
If you would invest 1,015 in Lion Biotechnologies on August 28, 2024 and sell it today you would lose (135.00) from holding Lion Biotechnologies or give up 13.3% of portfolio value over 90 days. Lion Biotechnologies is generating negative expected returns and assumes 4.4% volatility on return distribution over the 90 days horizon. Simply put, 39% of stocks are less volatile than Lion, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lion Biotechnologies Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lion Biotechnologies' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lion Biotechnologies, and traders can use it to determine the average amount a Lion Biotechnologies' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0286
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 2LB |
Estimated Market Risk
| 4.4 actual daily | 39 61% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lion Biotechnologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lion Biotechnologies by adding Lion Biotechnologies to a well-diversified portfolio.
Things to note about Lion Biotechnologies performance evaluation
Checking the ongoing alerts about Lion Biotechnologies for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lion Biotechnologies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lion Biotechnologies generated a negative expected return over the last 90 days | |
| Lion Biotechnologies has high historical volatility and very poor performance |
- Analyzing Lion Biotechnologies' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lion Biotechnologies' stock is overvalued or undervalued compared to its peers.
- Examining Lion Biotechnologies' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lion Biotechnologies' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lion Biotechnologies' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lion Biotechnologies' stock. These opinions can provide insight into Lion Biotechnologies' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Lion Stock Analysis
When running Lion Biotechnologies' price analysis, check to measure Lion Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lion Biotechnologies is operating at the current time. Most of Lion Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Lion Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lion Biotechnologies' price. Additionally, you may evaluate how the addition of Lion Biotechnologies to your portfolios can decrease your overall portfolio volatility.